Inventor · disambiguated record
Robert Flaumenhaft
Also filed as: FLAUMENHAFT ROBERT · FLAUMENHAFT ROBERT C · FLAUMENHAFT ROBERT CHARLES
7 granted patents·11 pending applications·8 citations·filing 2003–2025
76Inventor score
Files withBETH ISRAEL DEACONESS MEDICAL CT INC12BETH ISRAEL HOSPITAL2BROAD INST INC1DOCKENDORFF CHRIS1FLAUMENHAFT ROBERT C1
Top patents by PatentIndex Score
18 records- 0183US11872241B2Compositions and methods for reducing major thrombotic events in cancer patientsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Jan 16, 2024·2 cites·28 claims
- 0278US12290527B2Compositions and methods for reducing major thrombotic events in cancer patientsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2024·Granted May 6, 2025·0 cites·16 claims
- 0373US7166612B2Methods for reducing platelet activation platelet aggregaton or thrombosisBETH ISRAEL HOSPITAL·Filed 2003·Granted Jan 23, 2007·5 cites·1 claims
- 0470US12403123B2Method for treating sickle cell disease using quercetin-containing compositionsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2022·Granted Sep 2, 2025·0 cites·11 claims
- 0569US2025375411A1Method for treating sickle cell disease using quercetin-containing compositionsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2025·Application pending·0 cites
- 0667US2025262232A1Compositions and methods for reducing major thrombotic events in cancer patientsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2025·Application pending·0 cites
- 0762US2025134853A1Compounds and methods for using galloylated polyphenols to treat diseases mediated by thiol isomerasesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2024·Application pending·0 cites
- 0862US2025163181A1Anti-prothrombin antibodies targeting the open form of prothrombinUNIV SAINT LOUIS·Filed 2024·Application pending·0 cites
- 0961US9422262B2Compounds and methods for treating diseases mediated by protease activated receptorsDOCKENDORFF CHRIS·Filed 2011·Granted Aug 23, 2016·1 cites·7 claims
- 1058US2007060605A1Compositions and methods for inhibiting platelet activation and thrombosisFLAUMENHAFT ROBERT C·Filed 2006·Application pending·0 cites
- 1156US2024016777A1Compounds and methods for treating viral infectionsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2021·Application pending·0 cites
- 1256US2025189545A1Compositions and methods for evaluation of antiplatelet drug sensitivityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2025·Application pending·0 cites
- 1356US2008025918A1Invisible light fluorescent platelets for intraoperative detection of vascular thrombosisBETH ISRAEL HOSPITAL·Filed 2007·Application pending·0 cites
- 1455US12235278B2Compositions and methods for evaluation of antiplatelet drug sensitivityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Feb 25, 2025·0 cites·17 claims
- 1549US2016145209A1Compounds and compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomeraseBROAD INST INC·Filed 2014·Application pending·0 cites
- 1647US2024133897A1Compositions and methods for identifying and modulating thrombotic conditions in a cancer patientBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Application pending·0 cites
- 1746US10064853B2Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomeraseBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Sep 4, 2018·0 cites·18 claims
- 1836US2018370912A1Compounds and methods for treating diseases mediated by protein disulfide isomeraseBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Flaumenhaft files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →